









Markets
/
Stocks
/
nasdaq-fblg
/

Fibrobiologics Inc

FBLG

0.370USD

+0.043+13.24%

Close 11/05, 16:00（ET）Quotes delayed by 15 min

17.87MMarket Cap

LossP/E TTM



Fibrobiologics Inc

0.370

+0.043+13.24%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-52.42%-3.97M

-104.62%-3.98M

-23.39%-5.28M

-91.94%-3.07M

-128.80%-2.61M

-19.82%-1.95M

-109.97%-4.28M

-36.49%-1.60M

16.68%-1.14M

---1.63M

---2.04M

---1.17M

---1.37M

Net income from continuing operations

-1055.60%-5.78M

-618.71%-4.66M

41.30%-4.97M

68.11%-3.10M

77.19%-500.00K

141.55%898.00K

-250.31%-8.46M

-537.60%-9.72M

-40.33%-2.19M

---2.16M

---2.42M

---1.52M

---1.56M

Operating gains losses

71.05%65.00K

62.16%60.00K

51.43%53.00K

51.61%47.00K

192.31%38.00K

1750.00%37.00K

3400.00%35.00K

--31.00K

--13.00K

--2.00K

--1.00K

----

--0.00

Other non-cash items

58.10%166.00K

648.54%771.00K

5.88%108.00K

341.52%755.00K

6.06%105.00K

3.00%103.00K

-41.04%102.00K

-25.33%171.00K

-27.21%99.00K

--100.00K

--173.00K

--229.00K

--136.00K

Change in working capital

231.82%58.00K

-203.46%-479.00K

-471.12%-1.56M

-187.74%-279.00K

-108.73%-44.00K

752.11%463.00K

262.40%419.00K

253.33%318.00K

8500.00%504.00K

---71.00K

---258.00K

--90.00K

---6.00K

-Change in receivables

----

100.00%0.00

----

--275.00K

---275.00K

----

-Change in prepaid expenses

481.82%960.00K

-403.07%-691.00K

41.27%-417.00K

1522.22%128.00K

302.44%165.00K

1300.00%228.00K

-3450.00%-710.00K

-131.03%-9.00K

170.69%41.00K

---19.00K

---20.00K

--29.00K

---58.00K

-Change in payables and accrued expense

-2424.14%-732.00K

-2.54%384.00K

-63.49%-1.03M

452.00%1.52M

-113.06%-29.00K

1813.04%394.00K

-419.80%-630.00K

3.77%275.00K

200.00%222.00K

---23.00K

--197.00K

--265.00K

--74.00K

-Change in other current assets

--0.00

---30.00K

----

-100.00%0.00

100.00%0.00

97.18%-2.00K

556.25%105.00K

977.27%193.00K

---213.00K

---71.00K

--16.00K

---22.00K

-Change in other current liabilities

100.00%0.00

----

---1.86M

-155.32%-78.00K

---59.00K

--1.86M

--0.00

--141.00K

----

--0.00

----

Cash from non-recurring investing activities

Cash from operating activities

-52.42%-3.97M

-104.62%-3.98M

-23.39%-5.28M

-91.94%-3.07M

-128.80%-2.61M

-19.82%-1.95M

-109.97%-4.28M

-36.49%-1.60M

16.68%-1.14M

---1.63M

---2.04M

---1.17M

---1.37M

Investing cash flow

Net cash from continuing investing activities

-45.45%6.00K

222.73%213.00K

437.50%43.00K

4850.00%99.00K

-97.34%11.00K

175.00%66.00K

-85.71%8.00K

--2.00K

--413.00K

--24.00K

--56.00K

----

--0.00

Capital expenditures

-45.45%6.00K

222.73%213.00K

437.50%43.00K

4850.00%99.00K

-97.34%11.00K

175.00%66.00K

-85.71%8.00K

--2.00K

--413.00K

--24.00K

--56.00K

----

--0.00

Net cash flow from disposal of fixed assets

-45.45%6.00K

222.73%213.00K

437.50%43.00K

4850.00%99.00K

-97.34%11.00K

175.00%66.00K

-85.71%8.00K

--2.00K

--413.00K

--24.00K

--56.00K

----

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

45.45%-6.00K

-222.73%-213.00K

-437.50%-43.00K

-4850.00%-99.00K

97.34%-11.00K

-175.00%-66.00K

85.71%-8.00K

---2.00K

---413.00K

---24.00K

---56.00K

----

--0.00

Financing cash flow

Cash flow from continuous financing activities

-100.00%0.00

2643.60%4.38M

-100.00%0.00

--9.33M

375.64%4.47M

89.96%-172.00K

-77.50%3.28M

-100.00%0.00

413.33%940.00K

---1.71M

--14.57M

--2.15M

---300.00K

Net cash flow from debt Issuance/repayment

100.00%0.00

2643.60%4.38M

-100.00%0.00

--9.29M

---172.00K

-157.33%-172.00K

--459.00K

--0.00

100.00%0.00

--300.00K

--0.00

---300.00K

Net cash flow from common stock issuance/repurchase

----

-100.00%0.00

--45.00K

--4.64M

--0.00

--2.82M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--940.00K

--14.95M

--4.89M

--2.15M

--0.00

Net cash flow from other financing activities

----

-100.00%0.00

--0.00

---16.96M

--9.68M

----

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.00%0.00

2643.60%4.38M

-100.00%0.00

--9.33M

375.64%4.47M

89.96%-172.00K

-77.50%3.28M

-100.00%0.00

413.33%940.00K

---1.71M

--14.57M

--2.15M

---300.00K

Net cash flow

Beginning cash balance

48.08%8.85M

6.24%8.67M

52.62%13.98M

-27.30%7.83M

-47.50%5.97M

-44.65%8.16M

304.37%9.16M

735.22%10.77M

284.91%11.38M

--14.74M

--2.27M

--1.29M

--2.96M

Current period cash flow changes

-314.56%-3.98M

108.15%178.00K

-429.15%-5.32M

484.15%6.16M

402.94%1.85M

35.01%-2.19M

-108.06%-1.00M

-264.07%-1.60M

63.29%-612.00K

---3.36M

--12.47M

--977.00K

---1.67M

Ending cash balance

-37.82%4.87M

48.08%8.85M

6.24%8.67M

52.62%13.98M

-27.30%7.83M

-47.50%5.97M

-44.65%8.16M

304.37%9.16M

735.22%10.77M

--11.38M

--14.74M

--2.27M

--1.29M

Free cash flow

-52.01%-3.98M

-108.49%-4.20M

-24.17%-5.32M

-97.88%-3.17M

-68.62%-2.62M

-22.07%-2.01M

-104.73%-4.28M

---1.60M

-13.53%-1.55M

---1.65M

---2.09M

----

---1.37M

Currency unit

USD

Audit opinions

KeyAI

